Kraft Heinz is committed to improving nutritional profiles. It will no longer include artificial colors in new products and ...

Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He has long wanted to ...

A patient in Angola was the first in a groundbreaking human clinical trial approved by the U.S. Food and Drug Administration ...

In a sign of the importance of some of the imports and the damaging effect disruption could have on China's healthcare ...

Due to the study's results on cannabis use health risks, an editorial note published alongside the research called for the ...

Kraft Heinz will be pulling certain artificial dyes from its U.S. products starting in 2027 and will no longer roll out new ...

Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products with the dyes.

Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing project plans, stockpiling ...

Florida-based golf course operator Concert Golf Partners hopes to score big with the acquisition of The Club at New Seabury, ...

A bipartisan group of U.S. senators has reintroduced a bill designed to address ongoing shortages of generic drugs by expanding domestic stockpiles and manufacturing capacity. Here are three notes: ...

And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

Health and Human Services Secretary Robert F. Kennedy Jr. wants to make it harder and more expensive for drug companies to advertise to patients.